Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Tatsis Ourania Create: Alert

All | News | Filings
Date FiledTypeDescription
08/25/2023 4 Tatsis Ourania (EVP, Chief Reg. & Quality Off.) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 2,500 shares @ $355, valued at $887.5k
08/23/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 4 Tatsis Ourania (EVP, Chief Reg. & Quality Off.) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 5,750 shares @ $345.79, valued at $2M
08/10/2023 144 Form 144 - Report of proposed sale of securities:
02/28/2023 4 Tatsis Ourania (EVP, Chief Reg. & Quality Off.) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Paid exercise price by delivering 3,308 shares @ $289.12, valued at $956.4k
Sold 283 shares @ $287.2, valued at $81.3k
Sold 51 shares @ $288.33, valued at $14.7k
Sold 20 shares @ $289.29, valued at $5.8k
02/22/2023 4 Tatsis Ourania (EVP, Chief Reg. & Quality Off.) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Paid exercise price by delivering 4,498 shares @ $292.85, valued at $1.3M
Sold 4 shares @ $291.01, valued at $1.2k
Sold 145 shares @ $292.85, valued at $42.5k
Sold 207 shares @ $293.83, valued at $60.8k
Sold 124 shares @ $294.77, valued at $36.6k
02/14/2023 4 Tatsis Ourania (EVP, Chief Reg. & Quality Off.) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Paid exercise price by delivering 1,377 shares @ $294.33, valued at $405.3k
Paid exercise price by delivering 2,995 shares @ $298.26, valued at $893.3k
Sold 2 shares @ $295.84, valued at $591.7
Sold 78 shares @ $298.11, valued at $23.3k
Sold 120 shares @ $298.98, valued at $35.9k
Sold 64 shares @ $299.88, valued at $19.2k
Sold 11 shares @ $300.79, valued at $3.3k
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/26/2021 4 Tatsis Ourania (EVP, Chief Reg. & Quality Off.) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Paid exercise price by delivering 1,036 shares @ $217.57, valued at $225.4k
02/19/2021 4 Tatsis Ourania (EVP, Chief Reg. & Quality Off.) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Paid exercise price by delivering 2,000 shares @ $211.75, valued at $423.5k
02/12/2021 4 Tatsis Ourania (EVP, Chief Reg. & Quality Off.) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Paid exercise price by delivering 1,230 shares @ $214.16, valued at $263.4k
02/05/2021 4 Tatsis Ourania (EVP, Chief Reg. & Quality Off.) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Granted 2,814 shares @ $0
Granted 6,194 shares @ $0
Granted 13,952 shares @ $0
05/19/2020 4 Tatsis Ourania (EVP, Chief Regulatory Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 10 shares @ $276.35, valued at $2.8k
Sold 17 shares @ $279.93, valued at $4.8k
Sold 21 shares @ $281.23, valued at $5.9k
Sold 10 shares @ $284.3, valued at $2.8k
Sold 20 shares @ $286.12, valued at $5.7k
Sold 33 shares @ $287.61, valued at $9.5k
Sold 9 shares @ $288.38, valued at $2.6k
05/08/2020 4 Tatsis Ourania (EVP, Chief Regulatory Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 43 shares @ $268.8, valued at $11.6k
Sold 136 shares @ $270.19, valued at $36.7k
Sold 217 shares @ $272.09, valued at $59k
Sold 210 shares @ $273.15, valued at $57.4k
Sold 330 shares @ $274.13, valued at $90.5k
Sold 30 shares @ $275.3, valued at $8.3k
Exercised 559 options to buy @ $187.53, valued at $104.8k
Exercised 407 options to buy @ $155.57, valued at $63.3k
02/26/2020 4 Tatsis Ourania (SVP, CRO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Paid exercise price by delivering 1,036 shares @ $239.23, valued at $247.8k
Sold 416 shares @ $229.57, valued at $95.5k
Sold 160 shares @ $231.82, valued at $37.1k
Sold 80 shares @ $232.43, valued at $18.6k
Sold 240 shares @ $234.43, valued at $56.3k
Sold 160 shares @ $235.39, valued at $37.7k
Sold 240 shares @ $237.81, valued at $57.1k
02/19/2020 4 Tatsis Ourania (SVP, CRO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Paid exercise price by delivering 597 shares @ $241.5, valued at $144.2k
Sold 160 shares @ $241.82, valued at $38.7k
Sold 528 shares @ $242.78, valued at $128.2k
Sold 160 shares @ $243.78, valued at $39k
Sold 286 shares @ $244.99, valued at $70.1k
Sold 145 shares @ $245.75, valued at $35.6k
02/07/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/10/2020 4 Tatsis Ourania (SVP, CRO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 1,675 shares @ $227.53, valued at $381.1k
Exercised 1,675 options to buy @ $187.53, valued at $314.1k
11/19/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/15/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/03/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/03/2019 3 Form 3 - Initial statement of beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy